tirzepatide longevity Moody Trial - to Slow Biological Aging - Sealy Center on Aging Empowered+ Longevity Lifestyle Plan -

(Source: illumina.com) November 2024: Ascendis Pharma licensed its TransCon technology to Novo Nordisk for metabolic and cardiovascular drug development, including a monthly GLP-1 agonist for obesity and diabetes

Because weight health is part of whole health.

Many adults experience emotional and mental health symptoms linked to alcohol use, even without severe addiction

many dont

It contains , amino acids and microminerals, which helps nourish the skin, correct tear troughs and dark circles, improve hydration and firmness around the eyes, and reduce the appearance of fine lines in the preorbital area

The phase 2 trial found that starting at 2mg rather than 4mg significantly reduced nausea rates during escalation, validating the conservative titration approach